Spain: Monitoring visits in hospitals allowed again

2024-02-29T14:18:56+00:00June 8th, 2020|Categories: Clinical Trial, Covid-19, Europe, Western Europe|Tags: , , |

Good news from Spain! Our monitors informed us about the restart of onsite monitoring visits as of today June 8th, 2020 after the break imposed by the COVID-19 emergency. Meditrial is closely monitoring the situation in all countries to restart [...]

MPG Basic Course for Investigators, Deputies and Members of the Clinical Study Group – NEW at the Meditrial Academy Berlin

2024-02-29T13:51:45+00:00June 2nd, 2020|Categories: Europe, Regulatory, Western Europe|Tags: , , |

*** Deutsche Sprache unten *** MPG Basic Course for Investigators, Deputies and Members of the Clinical Study Group - NEW at the Meditrial Academy Berlin The MPG basic course based on the recommendations of the German Federal Medical Association [...]

Spain: AEMPS gives MedTech companies another 11 months to adapt to Brexit

2024-02-29T14:13:21+00:00May 29th, 2020|Categories: Covid-19, Europe, Regulatory, Western Europe|Tags: , , |

The Spanish Agency of Medicines and Medical Devices (AEMPS) moved to May 25th, 2021 the deadline for changing the labelling and instructions for use of medical devices due to Brexit. This decision aims at  allowing manufacturers to face the [...]

Netherland: CCMO announces conditions for (re)starting clinical trials in clinical research units

2024-02-29T13:53:58+00:00May 27th, 2020|Categories: Clinical Trial, Covid-19, Europe, Western Europe|Tags: , , , |

The Central Committee on Research Involving Human Subjects (CCMO) published a document with the conditions for the (re)start of studies in clinical research units. The document foresees a step-by-step relaxation of the restrictive measures. This makes it possible to [...]

Germany: DIMDI merges into BfArM

2024-02-26T11:15:21+00:00May 20th, 2020|Categories: Europe, Regulatory, Western Europe|Tags: , , , , , , |

DIMDI (Deutsche Institut für Medizinische Dokumentation und Information) and BfArM (Federal Institute for Drugs and Medical Devices) will join to become one agency on May 26th, 2020. Once DIMDI is merged into BfArM, the name that has been in [...]

SPAIN: Exceptional measures for clinical trials to manage problems due to COVID-19

2024-02-29T14:17:04+00:00May 5th, 2020|Categories: Clinical Trial, Covid-19, Europe, Western Europe|Tags: , , , , |

UPDATED ON May 5th, 2020 The Spanish Agency for Medicines and Health Products (AEMPS) provides recommendations for exceptional application during the period of the COVID-19 crisis in Spain. “It is important that the sponsor together with the investigator make [...]

Germany: BfArM Recommendations for clinical trials with medical devices during the COVID-19 pandemic

2024-02-26T11:12:52+00:00March 27th, 2020|Categories: Clinical Trial, Covid-19, Europe, Regulatory, Western Europe|Tags: , , , |

On March 26, 2020, the BfArM published "Additional recommendations on the European Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic " for clinical trials with medicinal products. All recommendations are aimed at: continue to ensure [...]

BELGIUM: FAMHP recommends electronic submission during COVID-19 emergency

2024-02-01T16:16:31+00:00March 25th, 2020|Categories: Europe, Western Europe|Tags: , , , , |

UPDATE ON March 25th, 2020 Federal Agency for Medicine and Health Products (FAMHP) recommends some specific measures for the COVID-19 emergency. Meditrial manages several studies in Belgium and has direct connections with Investigators, hospitals and local Ethics Committees. Please feel [...]

DENMARK: Extraordinary Measures for Clinical Trials due to COVID-19

2024-02-02T10:35:12+00:00March 24th, 2020|Categories: Europe, Western Europe|Tags: , , , , , |

UPDATE ON March 24th, 2020 Danish Medicines Agency (Lægemiddelstyrelsen) issued guidance regarding extraordinary measures  and further amendment dated March 24th for clinical trials during a pandemic emergency. The Agency is aware of Covid-19 influence on the conduct of clinical [...]

IRELAND: HPRA provides recommendations for clinical research management under COVID-19

2024-02-26T12:16:42+00:00March 23rd, 2020|Categories: Europe, Western Europe|Tags: , , , |

Health Product Regulatory Authority (HPRA) recommends some specific measures for the COVID-19 emergency. Meditrial manages several studies in Ireland and has direct connections with Investigators, hospitals and local Ethics Committees. Please feel free to contact us for advice and support. [...]

Go to Top